Report overview
Rheumatoid Arthritis Drugs include prescription and OTC.
This report contains market size and forecasts of Rheumatoid Arthritis Drugs in global, including the following market information:
Global Rheumatoid Arthritis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rheumatoid Arthritis Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Rheumatoid Arthritis Drugs companies in 2021 (%)
The global Rheumatoid Arthritis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prescription Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rheumatoid Arthritis Drugs include AbbVie, Amgen, Bayer, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche, Johnson and Johnson and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rheumatoid Arthritis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatoid Arthritis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Rheumatoid Arthritis Drugs Market Segment Percentages, by Type, 2021 (%)
Prescription Drugs
Over-the-counter Drugs
Global Rheumatoid Arthritis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Rheumatoid Arthritis Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Nursing Home
Other
Global Rheumatoid Arthritis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Rheumatoid Arthritis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rheumatoid Arthritis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rheumatoid Arthritis Drugs revenues share in global market, 2021 (%)
Key companies Rheumatoid Arthritis Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Rheumatoid Arthritis Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Bayer
Biogen
Boehringer Ingelheim
Bristol-Myers Squibb
F. Hoffmann-La Roche
Johnson and Johnson
Merck
Mitsubishi Tanabe Pharma
Novartis
Pfizer
UCB S.A
